1-6 of 6
Vadim Baykov
Close
Sort by
Journal Articles

The Outcomes of Nivolumab Fixed Dose 40 Mg Therapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Liudmila Fedorova, Kirill Lepik, Polina Kotselyabina, Elena Kondakova, Yuri Zalyalov, Evgeniya Borzenkova, Vadim Baykov, Olga S. Epifanovskaya, Elena V. Babenko, Ivan S. Moiseev, Aleksander Kulagin, Natalia Mikhailova, Boris Afanasyev
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-136620
Published: 2020
Journal Articles

Tumor Microenvironment in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma before and after Anti-PD-1 Therapy

Artem A. Gusak, Kirill V. Lepik, Natalia B. Mikhailova, MD PhD, Elena Kondakova, Yuri R. Zalaylov, Marina O. Popova, MD PhD, Tatiana I. Ionova, Prof., Aleksandr D. Kulagin, MD PhD, Boris V. Afanasyev, Vadim Baykov
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-138858
Published: 2020
Journal Articles

Treatment Efficacy and Outcomes in HIV-Related Plasmablastic Lymphoma: The Results of Multicenter Retrospective Study in Russia

Marina O. Popova, MD PhD, Yuliya A. Rogacheva, MD, Ivan V. Tsigankov, MD, Marina Demchenkova, Tatiana V. Shneider, MD, Kirill V. Lepik, Vadim Baykov, Natalia B. Mikhailova, MD PhD, Aleksandr D. Kulagin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-139839
Published: 2020
Journal Articles

Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

Elena V Morozova, MDPhD, Ivan S Moiseev, MD PhD, Maria V Barabanshikova, MDPhD, Elena I Darskaya, MDPhD, Sergey N. Bondarenko, PhDMD, Ludmila S Zubarovskaya, MD PhD Professor, Vadim Baykov, Alexandr L Alyanski, Ildar M Barkhatov, MD PhD, Axel R. Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor
Journal: Blood
Blood (2017) 130 (Supplement 1): 4492.
https://doi.org/10.1182/blood.V130.Suppl_1.4492.4492
Published: 2017
Journal Articles

Regaining the Tumor Control in Relapsed/Refractory Hodgkin Lymphoma after Nivolumab Failure with Addition of Another Antineoplastic Agent

Nataliia Mikhailova, Kirill Lepik, Elena Kondakova, Evgeniya Borzenkova, Yuri Zalaylov, Andrey Kozlov, Vadim Baykov, Lilia Stelmakh, Luibov Tsvetkova, Olesya Smykova, Axel R Zander, MD PhD Professor, Boris V Afanasyev, MD PhD Professor
Journal: Blood
Blood (2017) 130 (Supplement 1): 1521.
https://doi.org/10.1182/blood.V130.Suppl_1.1521.1521
Published: 2017
Journal Articles

A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells.

Magne Borset, M.D., Ph.D., Hakon Hov, M.D., Randi U. Holt, M.Sc., Torstein B. Ro, M.D., Unn-Merete Fagerli, M.D., Henrik Hjorth-Hansen, M.D., Ph.D., Vadim Baykov, M.D., Ph.D., James G. Christensen, Ph.D., Anders Waage, M.D., Ph.D., Anders Sundan, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2358.
https://doi.org/10.1182/blood.V104.11.2358.2358
Published: 2004